The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV
Open accessPublished version of a preprint
Abstract
With the ongoing outbreak of COVID-19, differences between SARS-CoV-2 and the original SARS-CoV could be leveraged to inform disease progression and eventual treatment options. In addition, these findings could have key implications for animal model development as well as further research into how SARS-CoV-2 modulates the type I IFN response early during infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Letko, M., Marzi, A., & Munster, V. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0688-y · Cited by 3,109
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984
Innate Immunity: The Virtues of a Nonclonal System of Recognition
Medzhitov, R., & Janeway, C. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80412-2 · Cited by 2,434 · cited 1×
“The host innate immune response is initiated when viral products are recognized by host cell pattern recognition receptors, including Toll-like receptors and RIG-I-like receptors (14, 15).”
BackgroundIsolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Return of the Coronavirus: 2019-nCoV
Gralinski, L. E., & Menachery, V. D. (2020) · Viruses · doi:10.3390/v12020135 · Cited by 1,348
Self-citationSARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
Frieman, M. B., Chen, J., Morrison, T. E., Whitmore, A., Funkhouser, W., Ward, J. M., Lamirande, E. W., Roberts, A., Heise, M., Subbarao, K., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000849 · Cited by 158
Research works printed but not linked: 49
- 10.1038/s41564-020-0695-z. · DOI · Paper page
- 10.1001/jama.2020.2648 · DOI · Paper page
- 10.1007/s11427-020-1637-5 · DOI · Paper page
- 10.1038/s41586-020-2012-7 · DOI · Paper page
- 10.1073/pnas.1922083117 · DOI · Paper page
- 10.1038/s41422-020-0282-0 · DOI · Paper page
- 10.1038/s41467-019-13940-6 · DOI · Paper page
- 10.1126/scitranslmed.aal3653 · DOI · Paper page
- 10.3390/v12030254 · DOI · Paper page
- 10.1016/j.molcel.2006.05.012 · DOI · Paper page
- 10.1007/3-540-32636-7_1 · DOI · Paper page
- 10.1038/nature09907 · DOI · Paper page
- 10.1038/nri1604 · DOI · Paper page
- 10.1016/j.tim.2013.06.006 · DOI
- 10.1016/j.cytogfr.2014.07.015 · DOI · Paper page
- 10.1016/S0140-6736(15)60454-8 · DOI · Paper page
- 10.3390/v11010059 · DOI · Paper page
- 10.1073/pnas.85.14.5259 · DOI · Paper page
- 10.1016/j.virusres.2014.11.019 · DOI · Paper page
- 10.1128/JVI.2.10.955-961.1968 · DOI · Paper page
- 10.1128/mBio.01174-14 · DOI · Paper page
- 10.1128/JVI.02520-12 · DOI · Paper page
- 10.1128/JVI.01619-09 · DOI · Paper page
- 10.1016/j.coviro.2012.04.004 · DOI · Paper page
- 10.1128/JVI.02582-15 · DOI · Paper page
- 10.1073/pnas.0506735102 · DOI · Paper page
- 10.1128/JVI.02406-09 · DOI · Paper page
- 10.1128/JVI.01782-06 · DOI · Paper page
- 10.1128/JVI.01012-07 · DOI · Paper page
- 10.1016/j.antiviral.2020.104742 · DOI · Paper page
- 10.3201/eid2605.200198 · DOI · Paper page
- 10.1128/JVI.03571-13 · DOI · Paper page
- 10.1016/j.cytogfr.2008.01.001 · DOI
- 10.1016/j.chom.2016.01.007 · DOI · Paper page
- 10.1074/jbc.AC120.013788 · DOI · Paper page
- 10.1128/mSphere.00346-17 · DOI
- 10.1038/srep01686 · DOI · Paper page
- 10.2165/00003495-199142050-00003 · DOI
- 10.1172/JCI126363 · DOI · Paper page
- 10.3390/jcm9030623 · DOI · Paper page
- 10.1371/journal.ppat.0030005 · DOI · Paper page
- 10.1038/nmicrobiol.2016.226 · DOI · Paper page
- 10.1073/pnas.1619109114 · DOI · Paper page
- 10.1016/j.chom.2016.03.010 · DOI · Paper page
- 10.3201/eid2606.200516 · DOI · Paper page
- 10.1128/mBio.00165-13 · DOI · Paper page
- 10.1128/JVI.00818-08 · DOI
- 10.1186/1465-9921-14-135 · DOI · Paper page
- 10.1128/JVI.01454-19 · DOI
Cited by
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Lamers, M. M., & Haagmans, B. L. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00713-0 · Cited by 983
Activation and evasion of type I interferon responses by SARS-CoV-2
Lei, X., Dong, X., Ma, R., Wang, W., Xiao, X., Tian, Z., Wang, C., Wang, Y., Li, L., Ren, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17665-9 · Cited by 980
Evasion of Type I Interferon by SARS-CoV-2
Xia, H., Cao, Z., Xie, X., Zhang, X., Chen, J. Y.-C., Wang, H., Menachery, V. D., Rajsbaum, R., & Shi, P.-Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108234 · Cited by 957
Self-citation
Metadata
- Authors
- Lokugamage, K. G., Hage, A., de Vries, M., Valero-Jimenez, A. M., Schindewolf, C., Dittmann, M., Rajsbaum, R., & Menachery, V. D.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2020-11-09
- Volume
- 94
- Issue
- 23
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W3085718285
- Cited by
- 483
- References
- 10
- FWCI
- 30.78
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Funders
- HHS | NIH | National Institute of Allergy and Infectious Diseases (U19AI100625, R24AI120942, R01AI134907, 1R01AI143639, 1R21AI139374, T32 AI007526)
- HHS | NIH | National Institute on Aging (R00AG049092)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. https://app.cochat.ai/papers/10.1128/jvi.01410-20
- The paper
- Lokugamage, K. G., Hage, A., de Vries, M., Valero-Jimenez, A. M., Schindewolf, C., Dittmann, M., Rajsbaum, R., & Menachery, V. D. (2020). Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. Journal of Virology. https://doi.org/10.1128/jvi.01410-20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.